DEA Registers More Than 900 Medical Marijuana Dispensaries

On October 30, 2026, the Drug Enforcement Administration began registering more than 900 medical marijuana dispensaries across Alabama, Florida and Mississippi, along with South Dakota, Texas, Virginia, and West Virginia. According to the Justice Department, the businesses met requirements for federal registration but officials did not identify which dispensaries were approved. It is the first time the DEA has issued registrations to medical marijuana businesses.

The registrations follow an April order by Attorney General Todd Blanche that moved state-licensed medical marijuana from Schedule I to Schedule III, a less restrictive federal classification. The order also established a faster registration process for state-licensed producers, manufacturers and distributors, subject to investigations and safeguards for security, records and inventory.

Federal registration could allow businesses to claim ordinary business expense deductions that have generally been unavailable to state-licensed cannabis companies. Nearly 7,000 other cannabis businesses have applied for registration, according to a DEA list. Blanche said regulated medical distribution would support access to chronic pain treatment and public safety. A medical cannabis advocacy group called the approvals a significant step for patients.

Important details remain unsettled. State cannabis rules do not necessarily match federal controls for Schedule III drugs, and it is unclear how the DEA will address operators with criminal histories or businesses that sell both medical and recreational cannabis. The agency’s next steps will help determine what registered companies must do to comply.

Federal Recognition Could Ease Burdens on Medical Cannabis

The DEA’s first registrations for medical marijuana dispensaries mark a major change for patients and state-licensed businesses long shut out of ordinary federal tax treatment. More than 900 dispensaries across Alabama, Florida and Mississippi, as well as South Dakota, Texas, Virginia, and West Virginia, are receiving approval, according to the Justice Department on October 30, 2026.

The move follows an April order shifting state-licensed medical marijuana from Schedule I to Schedule III and creating an expedited registration process. Registration could let businesses deduct ordinary costs such as rent, labor and advertising—expenses they have generally been unable to claim while cannabis remained federally classified as Schedule I. Nearly 7,000 other cannabis businesses have applied.

The change recognizes medical programs patients have fought to establish, while leaving practical questions for regulators and businesses. The DEA has not clarified how federal safeguards will fit with state systems, including rules for operators with criminal histories or companies serving both medical and recreational markets. The approvals could expand access, but the conditions attached to federal recognition will matter.

DEA Registration Brings Federal Oversight to Cannabis Businesses

The DEA has begun bringing more than 900 state-licensed medical marijuana dispensaries into a federal registration system, a consequential step in the Trump administration’s rescheduling policy. The Justice Department said on October 30, 2026, that dispensaries in seven states qualified, but did not name the businesses.

The registrations follow an April order moving medical marijuana from Schedule I to Schedule III. Businesses face a vetting review before registration and must comply with requirements involving security, records and inventory. Nearly 7,000 additional cannabis businesses have applied, and the DEA’s handling of those applications will determine how far the new system reaches.

The move may also let registered businesses deduct ordinary expenses on federal taxes, a benefit long denied to the industry. But federal oversight cannot be reduced to a tax advantage: state rules differ from those used for other Schedule III drugs, and the agency has yet to clarify how it will handle operators with criminal histories or businesses that combine medical and recreational sales. The coming requirements will show whether the system can maintain consistent controls.